Perampanel News
Perampanel currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Perampanel with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy....
- Evidence level: L5
- Predicted indications (20):
- visual epilepsy (99.9%)
- orgasm-induced seizures (99.9%)
- eating seizures (99.9%)
- micturation-induced seizures (99.9%)
- thinking seizures (99.9%)
- startle epilepsy (99.9%)
- audiogenic seizures (99.9%)
- reading seizures (99.8%)
- partial epilepsy (99.8%)
- beta-ketothiolase deficiency (99.8%)
- status epilepticus (99.8%)
- Rett syndrome, congenital variant (99.7%)
- 14q12 microdeletion syndrome (99.7%)
- guanidinoacetate methyltransferase deficiency (99.6%)
- partial motor epilepsy (99.4%)
- adolescent/adult onset autosomal dominant epilepsy with auditory features (99.1%)
- epilepsy (99.0%)
- epilepsy with generalized tonic-clonic seizures (99.0%)
- trigeminal nerve neoplasm (98.7%)
- trigeminal neuralgia (97.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.